NorthWest Biotherapeutics Inc (NWBO)

[Rootjim]

The problem I see with DCVax-L is no one is 100% sure that it will be FDA approved.I have not heard of anyone saying it is a slam dunk for FDA approval. Buy all we can and get 100 times on our money??
We are still measuring risk to reward.All the management can do at NWBO, is to try increasing the odds of DCVax-L success, at this point and time.
At the price NWBO is now, I would like to invest more. It would be hard to imagine the trial going beyond the last patient enrolled for 5 years. If DCVax-L is approved it would be a huge hurdle for the competition to overcome. IMO